Patent Expiry
PTHS: XEPI: recorded patent 9180200 expiry
January 29, 2032 · OZENOXACIN. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- January 29, 2032
- Company
- Pelthos Therapeutics Inc. (PTHS)
- Drug
- OZENOXACIN
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
XEPI: recorded patent 9180200 expiry
Orange Book application NDA208945, product 001, listed patent 9180200 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source
- Drug
- OZENOXACIN